FDA Opens a Pilot Program to Scrutinize Certain Laboratory D

FDA Opens a Pilot Program to Scrutinize Certain Laboratory Developed Tests, But Will It Generate Sufficient Interest? | Mintz

The U.S. Food and Drug Administration (FDA) announced a new pilot program on June 21, 2023 that gives sponsors of oncology products the opportunity to submit validation and performance...

Related Keywords

, Office Of Management , Pilot Program , Drug Administration , Verifying Accurate Leading Edge , Oncology Drug Products Used , Certain In Vitro Diagnostic Tests ,

© 2025 Vimarsana